Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 13 studies | 26% ± 8% | |
platelet | 8 studies | 24% ± 8% | |
erythrocyte | 7 studies | 44% ± 24% | |
hematopoietic stem cell | 6 studies | 40% ± 14% | |
erythroblast | 5 studies | 48% ± 26% | |
megakaryocyte | 4 studies | 37% ± 10% | |
megakaryocyte-erythroid progenitor cell | 4 studies | 50% ± 29% | |
hematopoietic precursor cell | 3 studies | 44% ± 14% | |
neutrophil | 3 studies | 17% ± 1% | |
conventional dendritic cell | 3 studies | 21% ± 3% | |
common myeloid progenitor | 3 studies | 31% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 39% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 90% | 99.91 | 586 / 653 | 77% | 2.77 | 467 / 605 |
lung | 100% | 1024.49 | 578 / 578 | 65% | 4.13 | 756 / 1155 |
skin | 71% | 190.51 | 1286 / 1809 | 41% | 1.44 | 193 / 472 |
spleen | 100% | 3494.43 | 241 / 241 | 0% | 0 | 0 / 0 |
kidney | 67% | 82.82 | 60 / 89 | 31% | 0.66 | 278 / 901 |
ovary | 7% | 6.94 | 12 / 180 | 89% | 7.50 | 381 / 430 |
peripheral blood | 81% | 24053.13 | 756 / 929 | 0% | 0 | 0 / 0 |
liver | 69% | 98.41 | 157 / 226 | 11% | 0.52 | 46 / 406 |
pancreas | 15% | 12.44 | 48 / 328 | 62% | 2.07 | 111 / 178 |
breast | 27% | 23.83 | 124 / 459 | 46% | 1.93 | 519 / 1118 |
uterus | 22% | 30.72 | 38 / 170 | 50% | 2.96 | 230 / 459 |
stomach | 29% | 42.35 | 105 / 359 | 40% | 2.19 | 113 / 286 |
bladder | 29% | 65.52 | 6 / 21 | 38% | 1.81 | 190 / 504 |
adipose | 61% | 151.01 | 729 / 1204 | 0% | 0 | 0 / 0 |
intestine | 19% | 21.54 | 181 / 966 | 39% | 1.80 | 205 / 527 |
heart | 46% | 58.58 | 392 / 861 | 0% | 0 | 0 / 0 |
esophagus | 22% | 24.29 | 316 / 1445 | 22% | 0.78 | 41 / 183 |
muscle | 41% | 48.39 | 326 / 803 | 0% | 0 | 0 / 0 |
brain | 17% | 13.68 | 443 / 2642 | 23% | 0.46 | 164 / 705 |
prostate | 36% | 31.97 | 87 / 245 | 4% | 0.05 | 21 / 502 |
blood vessel | 20% | 27.51 | 261 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.30 | 7 / 45 |
adrenal gland | 9% | 7.29 | 22 / 258 | 6% | 0.22 | 13 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007599 | Biological process | hemostasis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006337 | Biological process | nucleosome disassembly |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NFE2 |
Protein name | Nuclear factor (Erythroid-derived 2), 45kDa, isoform CRA_a (cDNA FLJ78141, highly similar to nuclear factor erythroid 2 isoform f=basic leucine zipper protein) (cDNA FLJ78153, highly similar to nuclear factor erythroid 2 isoform f=basic leucine zipper protein) (cDNA, FLJ93708, Homo sapiens nuclear factor (erythroid-derived 2), 45kDa (NFE2),mRNA) Nuclear factor, erythroid 2 Transcription factor NF-E2 45 kDa subunit (Leucine zipper protein NF-E2) (Nuclear factor, erythroid-derived 2 45 kDa subunit) (p45 NF-E2) Alternative protein NFE2 |
Synonyms | hCG_37258 |
Description | FUNCTION: Component of the NF-E2 complex essential for regulating erythroid and megakaryocytic maturation and differentiation. Binds to the hypersensitive site 2 (HS2) of the beta-globin control region (LCR). This subunit (NFE2) recognizes the TCAT/C sequence of the AP-1-like core palindrome present in a number of erythroid and megakaryocytic gene promoters. Requires MAFK or other small MAF proteins for binding to the NF-E2 motif. May play a role in all aspects of hemoglobin production from globin and heme synthesis to procurement of iron. . |
Accessions | ENST00000553198.1 ENST00000435572.7 A8K3E0 ENST00000312156.8 L8E770 ENST00000553070.5 F8W1N9 ENST00000540264.2 Q16621 |